Renergen Limited

Renergen Limited

RGNNF
Renergen LimitedUS flagOther OTC
0.56
USD
- -
- -
86.92MMarket Cap
2014 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.02
0.04
0.03
0.02
0.02
0.02
0.09
0.2
0.35
- -
Basic EPS, GAAP
- -
-0.21
-0.47
-0.47
-0.48
-0.36
-0.28
-0.2
-0.75
-1.59
- -
Free Cash Flow per Basic Share
- -
-0.54
-0.4
-0.58
-3.23
-1.79
-3.17
-3.8
-2.44
-1.83
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
1.18
1.01
2.07
2.18
1.68
2.25
6.08
8.29
6.81
- -
Tangible Book Value per Share
- -
0.27
0.15
1.23
1.44
1.73
2.21
6.06
8.82
7.35
- -
Basic Weighted Avg Shares
- -
81
80
87
110
117
122
135
147
148
- -
Sales/Revenue/Turnover
- -
2
3
3
3
2
3
13
29
52
- -
Operating Margin (%)
- -
-1,336.59
-1,128.77
-1,497.12
-1,947.59
-1,997.97
-1,590.06
-386.79
-415.45
-418.34
- -
Depreciation Expense
- -
2
3
3
5
5
6
5
21
63
- -
Net Income, GAAP
- -
-17
-38
-41
-53
-43
-34
-27
-110
-236
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-1,000.06
-1,306.07
-1,367.93
-1,996.93
-2,214.03
-1,279.86
-210.65
-380.88
-453.09
- -
Working Capital
- -
15
-6
91
136
122
82
-29
28
-999
- -
LT Debt
48
- -
31
40
354
537
774
808
760
63
- -
Total Equity
-14
89
69
164
247
206
286
840
1,321
1,115
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-42.85
-31.31
-25.1
-19.53
-14.31
-4.89
-10.84
-21.2
- -

Capital Structure

FRC

in mil. unless spec.
Nov'25
May'26
Aug'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Nov'25
May'26
Aug'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
51.45%
-15.63%
Free Cash Flow
- -
4.22%
-23.94%
Net Income, GAAP
- -
73.22%
114.12%
Sales/Revenue/Turnover
- -
119.87%
80%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
29
2025
- -
- -
- -
- -
52
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.75
2025
- -
- -
- -
- -
-1.59
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Stefano Marani
Full Time Employees
100
Sector
Energy
Industry
Oil & Gas Exploration & Production
Address
1 Bompas Road Johannesburg South Africa 2196
IPO Date
Aug 16, 2021
Business
Renergen Limited explores, develops and produces liquefied natural gas and liquefied helium from its Virginia Gas Project in South Africa's Free State province; it offers compressed natural gas, Cryo-Vacc technology for low-temperature vaccine transport without electrical power, and related energy solutions as a less carbon-intensive alternative to diesel for transport, thermal and power applications. Founded in 2005 and headquartered in Sandton, South Africa, the company holds a 94.5% equity interest in Tetra4 Proprietary Limited, which owns South Africa's first onshore petroleum production right valid until 2042, covering 1,870 square kilometers of gas fields with helium concentrations exceeding 3%. Renergen operates primarily in South Africa and sub-Saharan Africa, targeting industrial, medical, semiconductor, energy and space exploration markets with its high-purity helium and natural gas products. In 2025, Renergen entered into an agreement for its potential acquisition by ASP Isotopes Inc. via a scheme of arrangement, with shareholders approving the deal in July and closure expected by September 30 ahead of ASP's planned spin-out of Quantum Leap Energy; the transaction, supported by over 35% of shareholders, aims to create a global critical materials leader with synergies in isotopes, helium and fluorinated products, projecting over $300 million in EBITDA by 2030. The Virginia Gas Project has secured $40 million in U.S. International Development Finance Corporation funding, plus anticipated $750 million in debt from U.S. DFC and Standard Bank for expansion, while Phase 1 production of liquid helium commenced in January 2023 and continues ramping up. In May 2025, South Africa's Minister confirmed Renergen's helium rights and rejected a competitor's appeal.

Company News

APIChat